首页> 外文OA文献 >TLR4/MYD88-dependent, LPS-induced synthesis of PGE(2) by macrophages or dendritic cells prevents anti-CD3-mediated CD95L upregulation in T cells
【2h】

TLR4/MYD88-dependent, LPS-induced synthesis of PGE(2) by macrophages or dendritic cells prevents anti-CD3-mediated CD95L upregulation in T cells

机译:TLR4 / MYD88依赖的LPS诱导的巨噬细胞或树突状细胞的PGE(2)合成阻止T细胞中抗CD3介导的CD95L上调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antigen-presenting cells (APCs) control T-cell responses by multiple mechanisms, including the expression of co-stimulatory molecules and the production of cytokines and other mediators that control T-cell proliferation, survival and differentiation. Here, we demonstrate that soluble factor(s) produced by Toll-like receptor (TLR)-activated APCs suppress activation-induced cell death (AICD). This effect was observed in non-stimulated APCs, but it was significantly increased after lipopolysaccharide (LPS) treatment. Using different KO mice, we found that the LPS-induced protective factor is dependent on TLR4/MyD88. We identified the protective factor as prostaglandin E-2(PGE(2)) and showed that both APC-derived supernatants and PGE(2) prevented CD95L upregulation in T cells in response to TCR/CD3 stimulation, thereby avoiding both AICD and activated T cell killing of target macrophages. The PGE(2) receptors, EP2 and EP4, appear to be involved since pharmacological stimulation of these receptors mimics the protective effect on T cells and their respective antagonists interfere with the protection induced by either APCs derived or synthetic PGE(2). Finally, the engagement of EP2 and EP4 synergistically activates protein kinase A (PKA) and exchange protein directly activated by cAMP pathways to prevent AICD. Taken together, these results indicate that APCs can regulate T-cell levels of CD95L by releasing PGE2 in response to LPS through a TLR4/MyD88-dependent pathway, with consequences for both T cell and their own survival.
机译:抗原呈递细胞(APC)通过多种机制控制T细胞反应,包括共刺激分子的表达以及细胞因子和其他控制T细胞增殖,存活和分化的介质的产生。在这里,我们证明了由Toll样受体(TLR)激活的APC产生的可溶性因子抑制激活诱导的细胞死亡(AICD)。在未刺激的APC中观察到此效果,但在脂多糖(LPS)处理后,其效果显着增强。使用不同的KO小鼠,我们发现LPS诱导的保护因子取决于TLR4 / MyD88。我们确定保护因子为前列腺素E-2(PGE(2)),并显示APC衍生的上清液和PGE(2)均能防止TCR / CD3刺激引起T细胞CD95L上调,从而避免AICD和活化T靶巨噬细胞的细胞杀伤。 PGE(2)受体EP2和EP4似乎参与其中,因为这些受体的药理刺激模拟了对T细胞的保护作用,并且它们各自的拮抗剂干扰了衍生自APC或合成PGE(2)诱导的保护作用。最后,EP2和EP4的结合可协同激活蛋白激酶A(PKA),并交换被cAMP途径直接激活的蛋白,从而预防AICD。综上所述,这些结果表明,APC可以通过经由TLR4 / MyD88依赖性途径响应LPS释放PGE2来调节CD95L的T细胞水平,从而对T细胞及其自身生存产生影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号